Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $4.83 Million - $29.5 Million
-19,544 Reduced 83.22%
3,940 $1.02 Million
Q2 2022

Aug 11, 2022

BUY
$237.11 - $299.66 $5.03 Million - $6.35 Million
21,201 Added 928.65%
23,484 $5.95 Million
Q1 2022

May 12, 2022

SELL
$257.27 - $315.76 $5.14 Million - $6.31 Million
-19,990 Reduced 89.75%
2,283 $670,000
Q4 2021

Feb 09, 2022

BUY
$292.08 - $329.01 $4.4 Million - $4.96 Million
15,078 Added 209.56%
22,273 $7.33 Million
Q3 2021

Nov 10, 2021

SELL
$272.21 - $332.43 $5.85 Million - $7.15 Million
-21,498 Reduced 74.92%
7,195 $2.19 Million
Q2 2021

Aug 12, 2021

SELL
$225.08 - $271.69 $388,713 - $469,208
-1,727 Reduced 5.68%
28,693 $7.7 Million
Q1 2021

May 13, 2021

SELL
$212.38 - $245.9 $1.5 Million - $1.73 Million
-7,041 Reduced 18.8%
30,420 $6.85 Million
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $7.61 Million - $8.79 Million
35,793 Added 2145.86%
37,461 $8.32 Million
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $149,700 - $181,953
-845 Reduced 33.63%
1,668 $359,000
Q2 2020

Aug 12, 2020

SELL
$128.7 - $176.83 $1.71 Million - $2.35 Million
-13,265 Reduced 84.07%
2,513 $444,000
Q1 2020

May 13, 2020

BUY
$121.39 - $169.05 $1.56 Million - $2.18 Million
12,889 Added 446.14%
15,778 $2.18 Million
Q4 2019

Feb 12, 2020

BUY
$133.47 - $153.48 $200,471 - $230,526
1,502 Added 108.29%
2,889 $443,000
Q3 2019

Nov 12, 2019

SELL
$135.4 - $146.47 $658,314 - $712,137
-4,862 Reduced 77.8%
1,387 $200,000
Q2 2019

Aug 12, 2019

BUY
$124.88 - $143.73 $780,375 - $898,168
6,249 New
6,249 $893,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.